The FDA approved SSRI anti-depressant drug Effexor for distribution in 1993. The medication was developed to treat depression, anxiety, and other issues affecting the chemicals in the brain. Many cases have been brought against Wyeth Pharmaceuticals, the drug’s manufacturer, for marketing the medication to pregnant women, despite known risks to unborn infants.
In 2012, two families filed suit against Wyeth for damages sustained by fetuses in utero while the pregnant mothers took Effexor. The allegations included that the patients were not informed of the risk to their babies, which violates the legal responsibility of manufacturers to disclose all known potential hazards involved with medications they produce.
Birth Defects caused by Effexor can include:
- Aortic stenosis
- Cleft lip or palate
- Club foot
- Congenital heart defects
- Malformation of the heart or lungs
- Persistent pulmonary hypertension in newborn (PPHN)
- Pulmonary stenosis
- Spina bifida
These birth defects can cause intense emotional and financial strain on the families of affected infants. Those born with serious defects may face difficulties and complications for the rest of their lives. Most birth defects are likely to develop during the first trimester of pregnancy, making Effexor dangerous for women who even suspect that they might be pregnant and for those who may not even know. When a manufacturing company neglects to reveal potential risks to patients and physicians, they are responsible for the life-altering consequences that can occur.
If your child has fallen victim to a birth defect due to Effexor, you may have grounds to seek compensation. The attorneys of Blizzard & Nabers have helped clients across the country successfully navigate the complex process of seeking compensation with as little stress as possible, so that our clients can focus on their children.